Changing demographics and risk factors for cryptococcosis: A 12-year review at a tertiary care centre.
Abstract
Background: Cryptococcosis is classically associated with the immunocompromised patients but there is a rising appreciation for its impact on the immunocompetent hosts. We sought to analyse the trends, diagnosis, treatment of different hosts and the effect of immunodeficiency and chronic liver disease on relapse and in‐house mortality. Methods: This is a retrospective study of 12 years of patients with cryptococcosis, divided into three different groups: HIV‐infected, transplant and non‐HIV non‐transplant (NHNT). Data were analysed with Chi‐square, unpaired parametric t test, simple and multivariate logistic regression analysis. Results: Of 114 identified patients, 23 (20.2%) had HIV infection, 11 (9.6%) had transplant, 80 (70.2%) were NHNT patients. Overall, mortality was 28.1% (32/114) and relapse occurred in 10.5% (12/114) of patients. The mortality trend was higher (OR = 2.346, p = .287) in the transplant group (45.5%, 5/11) than in HIV (26.1%, 6/23) and NHNT groups (26.3%, 21/80). HIV was associated with relapse; 30.4% (7/23) for HIV‐positive patients and 5.5% (5/91) for HIV‐negative patients (OR = 7.525, p = .002). Chronic liver disease had a large and statistically significant association with mortality on multivariate analysis (OR = 3.583, p = .013) which was more pronounced than the HIV or transplant groups. It was independently associated with mortality by chi‐square analysis (OR 3.137, p = .012). Conclusion: Chronic liver disease represented 30.7% (35/114) of all studied patients. It was a risk factor for in‐hospital mortality. HIV infection and transplant were not statistically significant for mortality. Relapse was highest in the HIV‐infected patients at 30.4% (7/23). These data highlight the effect of type and degree of immunocompromise on cryptococcosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a single-center retrospective study of individuals with cryptococcosis, cryptococcosis in Hispanic persons and black or African American persons was more common in the HIV-infected group compared to the transplant and non-HIV/non-transplant groups (p < 0.0001).
“Cryptococcosis in Hispanic persons and black or African American persons was more common in the HIV-infected group compared to the transplant and non-HIV/non-transplant (NHNT) groups (p < 0.0001).”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [129]
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660 · see citing works
Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N. P., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,013 · see citing works
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570 · see citing works
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698 · see citing works
Pappas, P. G., Perfect, J. R., Cloud, G. A., Larsen, R. A., Pankey, G. A., Lancaster, D. J., Henderson, H. M., Kauffman, C. A., Haas, D. W., Saccente, M., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322597 · Cited by 640 · see citing works
Cryptococcal Disease in Patients with the Acquired Immunodeficiency Syndrome
ZUGER, A., Louie, E., Holzman, R. S., Simberkoff, M. S., & Rahal, J. J. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-2-234 · Cited by 523 · see citing works
Brizendine, K. D., Baddley, J. W., & Pappas, P. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060431 · Cited by 265 · see citing works
Defective Chemotaxis Associated with a Serum Inhibitor in Cirrhotic Patients
DeMeo, A. N., Andersen, B. R., English, D. K., & Peterson, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197204062861401 · Cited by 224 · see citing works
Bratton, E. W., Husseini, N. E., Chastain, C. A., Lee, M. S., Poole, C., Stürmer, T., Juliano, J. J., Weber, D. J., & Perfect, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043582 · Cited by 203 · see citing works
Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
Dromer, F., Mathoulin‐Pélissier, S., Fontanet, A. L., Ronin, O., Dupont, B., & Lortholary, O. (2004) · AIDS · doi:10.1097/00002030-200402200-00024 · Cited by 193 · see citing works
Mandell, Douglas, and Bennett's Principles and practice of Infectious Diseases
Wright, S. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90043-5 · Cited by 169 · see citing works
Hagen, F., Lumbsch, H. T., Arsić-Arsenijević, V. S., Badali, H., Bertout, S., Billmyre, R. B., Bragulat, M. R., Cabañes, F. J., Carbia, M., Chakrabarti, A., et al. (2017) · mSphere · doi:10.1128/msphere.00238-17 · Cited by 144 · see citing works
Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory
McMullan, B. J., Halliday, C. L., Sorrell, T. C., Judd, D., Sleiman, S., Marriott, D., Olma, T., & Chen, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049541 · Cited by 127 · see citing works
George, I. A., Spec, A., Powderly, W. G., & Santos, C. A. Q. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix867 · Cited by 116 · see citing works
Comparison of Four Assays for the Detection of Cryptococcal Antigen
Binnicker, M. J., Jespersen, D. J., Bestrom, J. E., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00446-12 · Cited by 110 · see citing works
Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A. A., Bennett, J. E., Pappas, P. G., Ostrander, D. B., Datta, K., Zhang, S. X., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz193 · Cited by 102 · see citing works
Cryptococcosis in China (1985–2010): Review of Cases from Chinese Database
Yuchong, C., Fubin, C., Jianghan, C., et al. (2011) · Mycopathologia · doi:10.1007/s11046-011-9471-1 · Cited by 97 · see citing works
Cell-mediated Immune Responses in Chronic Liver Diseases
Smith, M. G. M., Golding, P. L., Eddleston, A. L. W. F., et al. (1972) · BMJ · doi:10.1136/bmj.1.5799.527 · Cited by 90 · see citing works
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation
Desnos‐Ollivier, M., Patel, S., Raoux‐Barbot, D., et al. (2015) · mBio · doi:10.1128/mbio.00311-15 · Cited by 75 · see citing works
Hevey, M. A., George, I. A., Raval, K., Powderly, W. G., & Spec, A. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.026 · Cited by 71 · see citing works
van Elden, L. J. R., Walenkamp, A., Lipovsky, M. M., et al. (2000) · AIDS · doi:10.1097/00002030-200012010-00019 · Cited by 68 · see citing works
T and B cell function in alcoholic liver disease
Nouri‐Aria, K. T., Alexander, G., Portmann, B. C., Hegarty, J. E., Eddleston, A. L. W. F., & Williams, R. L. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80078-2 · Cited by 67 · see citing works
Davis, J. A., Horn, D. L., Marr, K. A., & Fishman, J. A. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00424.x · Cited by 65 · see citing works
End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis
Spec, A., Raval, K., & Powderly, W. G. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv197 · Cited by 65 · see citing works
Cryptococcal Infections: Changing Epidemiology and Implications for Therapy
Hoz, R. M. L., & Pappas, P. G. (2013) · Drugs · doi:10.1007/s40265-013-0037-z · Cited by 59 · see citing works
Galanis, E., Hoang, L., Kibsey, P., Morshed, M. G., & Phillips, P. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2009/719659 · Cited by 55 · see citing works
Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)
Perfect, J. R. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00264-2 · Cited by 37 · see citing works
Serum Bactericidal and Opsonic Activities in Patients with Non-Alcoholic Cirrhosis
Akalın, H., Laleli, Y. R., & TELATAR, H. (1985) · QJM · doi:10.1093/oxfordjournals.qjmed.a067889 · Cited by 31 · see citing works
Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
Mpoza, E., Mukaremera, L., Kundura, D. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190652 · Cited by 26 · see citing works
Cryptococcosis in non-HIV/non-transplant patients: A Brazilian case series
Lomes, N. R., Melhem, M. D. S. C., Szeszs, M. W., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myw021 · Cited by 24 · see citing works
Gassiep, I., Douglas, J., Emeto, T. I., et al. (2018) · Mycoses · doi:10.1111/myc.12783 · Cited by 21 · see citing works
Herkert, P. F., Meis, J. F. G. M., Salvador, G. L. D. O., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000698 · Cited by 19 · see citing works
Cryptococcal Meningitis with Normal Cerebrospinal Fluid
Shaunak, S., Schell, W. A., & Perfect, J. R. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.912 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55 · see citing works
- Authors
- Bhatt, M., Porterfield, J. Z., Ribes, J. A., Arora, V., & Myint, T.
- Affiliations
- North Mississippi Medical Center (US)
- University of Kentucky (US)
- Corresponding author
- Myint, Thein
- Venue
- Mycoses
- Publisher
- Wiley
- Published
- 2021-06-10
- Volume
- 64
- Issue
- 9
- Pages
- 1073-1082
- ISSN
- 0027-5557 (ISSN-L)
- 0933-7407
- 1439-0507
- OpenAlex
- W3164807279
- Cited by
- 13
- References
- 33
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mycoses (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Parasitic infections in humans and animals
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Keywords
- cryptococcosis, cryptococcal meningitis, immunocompromised patients, HIV infection, organ transplantation, chronic liver disease, in-hospital mortality, relapse, risk factors, immunosuppression
- MeSH terms
- Cryptococcosis, Humans, Recurrence, Retrospective Studies, Risk Factors, HIV Infections, End Stage Liver Disease, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review